Puma Biotechnology, Inc. (PBYI)
USD 2.88
(-1.54%)
USD 2.88
(-1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 177.08 Million USD | -11.66% |
| 2022 | 200.45 Million USD | -12.48% |
| 2021 | 229.03 Million USD | -8.45% |
| 2020 | 250.17 Million USD | 15.05% |
| 2019 | 217.44 Million USD | -3.28% |
| 2018 | 224.81 Million USD | 100.33% |
| 2017 | 112.22 Million USD | 161.19% |
| 2016 | 42.96 Million USD | 26.99% |
| 2015 | 33.83 Million USD | -25.98% |
| 2014 | 45.71 Million USD | 124.21% |
| 2013 | 20.38 Million USD | -10.54% |
| 2012 | 22.79 Million USD | 2122.04% |
| 2011 | 1.02 Million USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 2270.00 USD | 0.93% |
| 2008 | 2249.00 USD | -99.84% |
| 2007 | 1.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 156.49 Million USD | -4.09% |
| 2024 Q1 | 163.16 Million USD | -7.86% |
| 2023 FY | 177.08 Million USD | -11.66% |
| 2023 Q2 | 170.09 Million USD | -0.18% |
| 2023 Q3 | 164.86 Million USD | -3.08% |
| 2023 Q4 | 177.08 Million USD | 7.41% |
| 2023 Q1 | 170.41 Million USD | -14.99% |
| 2022 Q3 | 176.61 Million USD | 1.55% |
| 2022 FY | 200.45 Million USD | -12.48% |
| 2022 Q1 | 193.54 Million USD | -15.5% |
| 2022 Q2 | 173.91 Million USD | -10.14% |
| 2022 Q4 | 200.45 Million USD | 13.5% |
| 2021 Q4 | 229.03 Million USD | -3.45% |
| 2021 FY | 229.03 Million USD | -8.45% |
| 2021 Q1 | 242.22 Million USD | -3.18% |
| 2021 Q2 | 230.52 Million USD | -4.83% |
| 2021 Q3 | 237.2 Million USD | 2.9% |
| 2020 Q4 | 250.17 Million USD | -4.57% |
| 2020 FY | 250.17 Million USD | 15.05% |
| 2020 Q1 | 216.15 Million USD | -0.59% |
| 2020 Q2 | 240.41 Million USD | 11.22% |
| 2020 Q3 | 262.14 Million USD | 9.04% |
| 2019 Q4 | 217.44 Million USD | 1.2% |
| 2019 FY | 217.44 Million USD | -3.28% |
| 2019 Q1 | 287.88 Million USD | 28.05% |
| 2019 Q2 | 218.08 Million USD | -24.24% |
| 2019 Q3 | 214.86 Million USD | -1.48% |
| 2018 FY | 224.81 Million USD | 100.33% |
| 2018 Q3 | 184.81 Million USD | -2.38% |
| 2018 Q2 | 189.32 Million USD | 68.76% |
| 2018 Q1 | 112.18 Million USD | -0.04% |
| 2018 Q4 | 224.81 Million USD | 21.65% |
| 2017 FY | 112.22 Million USD | 161.19% |
| 2017 Q4 | 112.22 Million USD | 9.28% |
| 2017 Q3 | 102.69 Million USD | 94.82% |
| 2017 Q2 | 52.71 Million USD | 7.07% |
| 2017 Q1 | 49.23 Million USD | 14.58% |
| 2016 Q4 | 42.96 Million USD | 0.19% |
| 2016 Q3 | 42.88 Million USD | -2.13% |
| 2016 FY | 42.96 Million USD | 26.99% |
| 2016 Q2 | 43.81 Million USD | 8.91% |
| 2016 Q1 | 40.23 Million USD | 18.9% |
| 2015 Q2 | 27.58 Million USD | 0.13% |
| 2015 Q1 | 27.54 Million USD | -39.73% |
| 2015 Q4 | 33.83 Million USD | 26.33% |
| 2015 FY | 33.83 Million USD | -25.98% |
| 2015 Q3 | 26.78 Million USD | -2.9% |
| 2014 FY | 45.71 Million USD | 124.21% |
| 2014 Q1 | 21.46 Million USD | 5.29% |
| 2014 Q3 | 30.45 Million USD | 4.86% |
| 2014 Q2 | 29.03 Million USD | 35.28% |
| 2014 Q4 | 45.71 Million USD | 50.11% |
| 2013 Q2 | 20.95 Million USD | -7.84% |
| 2013 Q4 | 20.38 Million USD | 0.19% |
| 2013 Q3 | 20.34 Million USD | -2.91% |
| 2013 Q1 | 22.74 Million USD | -0.21% |
| 2013 FY | 20.38 Million USD | -10.54% |
| 2012 Q4 | 22.79 Million USD | -17.11% |
| 2012 Q2 | 16.39 Million USD | 60.34% |
| 2012 FY | 22.79 Million USD | 2122.04% |
| 2012 Q1 | 10.22 Million USD | 897.09% |
| 2012 Q3 | 27.49 Million USD | 67.68% |
| 2011 Q2 | 3280.00 USD | 36.1% |
| 2011 Q4 | 1.02 Million USD | 183.29% |
| 2011 Q3 | 362.04 Thousand USD | 10938.05% |
| 2011 FY | 1.02 Million USD | 0.0% |
| 2011 Q1 | 2410.00 USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2009 Q2 | 2279.00 USD | 355.8% |
| 2009 Q1 | 500.00 USD | -77.77% |
| 2009 FY | 2270.00 USD | 0.93% |
| 2009 Q4 | 2270.00 USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2008 Q1 | 2.16 Million USD | 53.94% |
| 2008 Q3 | 2.24 Million USD | 349.8% |
| 2008 Q4 | 2249.00 USD | -99.9% |
| 2008 FY | 2249.00 USD | -99.84% |
| 2008 Q2 | 500 Thousand USD | -76.92% |
| 2007 FY | 1.4 Million USD | 0.0% |
| 2007 Q3 | 8.61 Million USD | 0.0% |
| 2007 Q4 | 1.4 Million USD | -83.67% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 47.261% |
| Alkermes plc | 933.53 Million USD | 81.031% |
| Agenus Inc. | 462.29 Million USD | 61.694% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 95.628% |
| Aptorum Group Limited | 5.25 Million USD | -3268.743% |
| Ardelyx, Inc. | 130.76 Million USD | -35.425% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 62.983% |
| Bicycle Therapeutics plc | 224.41 Million USD | 21.089% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -36.0% |
| ChromaDex Corporation | 26.5 Million USD | -568.047% |
| Chimerix, Inc. | 19.74 Million USD | -796.865% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -403.413% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -144.031% |
| CRISPR Therapeutics AG | 346.76 Million USD | 48.932% |
| Precision BioSciences, Inc. | 140.92 Million USD | -25.664% |
| Dyadic International, Inc. | 2.34 Million USD | -7465.673% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -988.889% |
| Fortress Biotech, Inc. | 165.93 Million USD | -6.718% |
| Lantern Pharma Inc. | 2.73 Million USD | -6363.743% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -147.742% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -4918.413% |
| Incyte Corporation | 1.59 Billion USD | 88.878% |
| IO Biotech, Inc. | 17.55 Million USD | -908.692% |
| Jaguar Health, Inc. | 45.86 Million USD | -286.094% |
| Novavax, Inc. | 2.57 Billion USD | 93.116% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -391.114% |
| Opthea Limited | 264.6 Million USD | 33.074% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -35.483% |
| ContextLogic Inc. | 206 Million USD | 14.036% |
| MiMedx Group, Inc. | 96.33 Million USD | -83.833% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -268.76% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -4918.183% |
| NextCure, Inc. | 14.99 Million USD | -1080.809% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -4281.148% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -2552.179% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -278.883% |
| Vaxcyte, Inc. | 167.44 Million USD | -5.755% |
| PDS Biotechnology Corporation | 33.25 Million USD | -432.443% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | 24.713% |
| Pharming Group N.V. | 244.07 Million USD | 27.445% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -1385.372% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -38.575% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -2580.165% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -2580.165% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -114.824% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -2565.753% |
| Acelyrin, Inc. | 86.35 Million USD | -105.072% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -13529.958% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1131.56% |
| Summit Therapeutics Inc. | 125.25 Million USD | -41.378% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -1768.193% |
| Senti Biosciences, Inc. | 52.57 Million USD | -236.851% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -157.479% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -16.879% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -8953.476% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -13159.267% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | 21.931% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -1790.531% |
| Wave Life Sciences Ltd. | 227.44 Million USD | 22.141% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 64.19% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -1522.558% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -543.692% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -1362.953% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 63.608% |
| Immix Biopharma, Inc. | 3.72 Million USD | -4658.096% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -368.333% |
| MEI Pharma, Inc. | 8.35 Million USD | -2019.521% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -510.326% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 49.052% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -21.401% |
| Fortress Biotech, Inc. | 165.93 Million USD | -6.718% |
| Precigen, Inc. | 41.64 Million USD | -325.238% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -254.669% |
| AlloVir, Inc. | 45.01 Million USD | -293.393% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -35.868% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -28.509% |
| ImmuCell Corporation | 18.81 Million USD | -841.195% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -527.386% |
| Onconetix, Inc. | 23.18 Million USD | -663.931% |
| PureTech Health plc | 125.58 Million USD | -41.011% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -1878.615% |
| Elevation Oncology, Inc. | 34.28 Million USD | -416.557% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -7142.781% |
| Seer, Inc. | 39.36 Million USD | -349.856% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -186.389% |
| Innoviva, Inc. | 568.55 Million USD | 68.853% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -550.382% |
| ESSA Pharma Inc. | 3.49 Million USD | -4966.735% |
| GlycoMimetics, Inc. | 6.9 Million USD | -2465.693% |
| GT Biopharma, Inc. | 6.63 Million USD | -2569.772% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | 33.021% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 34.963% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -110.751% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -1711.807% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -551.794% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -5389.723% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -140.061% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1020.181% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -1504.085% |
| Soligenix, Inc. | 7.27 Million USD | -2334.204% |
| Century Therapeutics, Inc. | 175.94 Million USD | -0.651% |
| Kura Oncology, Inc. | 51.66 Million USD | -242.778% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -46.012% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -4184.684% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -2577.5% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | 29.894% |
| Autolus Therapeutics plc | 263.9 Million USD | 32.898% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -1589.429% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -99.284% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -277.59% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 49.814% |
| GRI Bio, Inc. | 2.69 Million USD | -6466.036% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -21773.676% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -469.573% |
| IGM Biosciences, Inc. | 220.17 Million USD | 19.571% |
| INmune Bio, Inc. | 18.86 Million USD | -838.851% |
| Heron Therapeutics, Inc. | 256.47 Million USD | 30.955% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -564.692% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -6414.332% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -5298.526% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -202.944% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -84.16% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 33.108% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 78.484% |
| Verastem, Inc. | 71.18 Million USD | -148.769% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -260.107% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -359.034% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -261.902% |
| Histogen Inc. | 5.69 Million USD | -3008.408% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -3937.892% |
| Surrozen, Inc. | 8.14 Million USD | -2074.168% |
| Organovo Holdings, Inc. | 2.74 Million USD | -6344.178% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -56322.331% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -214.932% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -972.469% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -246.528% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -21316.296% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -39.74% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -1537.625% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -17.362% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -6691.813% |
| Apollomics, Inc. | 14.15 Million USD | -1151.226% |
| Amarin Corporation plc | 279.58 Million USD | 36.662% |
| Mesoblast Limited | 188.79 Million USD | 6.203% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1151.668% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | 2.048% |
| Synaptogenix, Inc. | 5.52 Million USD | -3102.586% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -2563.748% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -4.102% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -1969.44% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -9976.631% |
| Exelixis, Inc. | 678.44 Million USD | 73.898% |
| Better Therapeutics, Inc. | 23.84 Million USD | -642.748% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -7.949% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 70.198% |
| NLS Pharmaceutics AG | 10.68 Million USD | -1558.077% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -10806.889% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -354.918% |
| Gritstone bio, Inc. | 125.91 Million USD | -40.635% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1106.637% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -3380.035% |
| Avid Bioservices, Inc. | 275.66 Million USD | 35.761% |
| Insmed Incorporated | 1.66 Billion USD | 89.343% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -2201.604% |
| MediWound Ltd. | 27.18 Million USD | -551.363% |
| OmniAb, Inc. | 87.4 Million USD | -102.616% |
| Alector, Inc. | 487.66 Million USD | 63.687% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 56.108% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -861.118% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -361.486% |
| Zai Lab Limited | 240.17 Million USD | 26.269% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 71.894% |
| Aura Biosciences, Inc. | 29.22 Million USD | -505.899% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -86.255% |
| Immunic, Inc. | 25.36 Million USD | -598.068% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -155.772% |
| Veracyte, Inc. | 93.71 Million USD | -88.954% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -6667.601% |
| FibroGen, Inc. | 585.72 Million USD | 69.767% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -918.731% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -27015.68% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -3031.241% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 97.687% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -2060.112% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -110.761% |
| TG Therapeutics, Inc. | 169.08 Million USD | -4.732% |
| Galecto, Inc. | 5.89 Million USD | -2903.494% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -2037.687% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 93.237% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -514.413% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1303.106% |
| XBiotech Inc. | 8.39 Million USD | -2008.92% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1106.637% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -232.994% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 51.23% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -558.704% |
| Theravance Biopharma, Inc. | 169 Million USD | -4.782% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 85.432% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 64.613% |
| Vaxxinity, Inc. | 30.94 Million USD | -472.279% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 81.79% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -2836.211% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 76.238% |
| NexImmune, Inc. | 5.08 Million USD | -3383.043% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -47581.438% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -5659.179% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 97.508% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -3335.874% |
| Scopus BioPharma Inc. | 7.45 Million USD | -2275.579% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -573.484% |
| Ainos, Inc. | 7.39 Million USD | -2294.924% |
| Pluri Inc. | 34.11 Million USD | -419.131% |
| Prothena Corporation plc | 135.01 Million USD | -31.158% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | 27.156% |
| Celularity Inc. | 102.92 Million USD | -72.047% |
| Rallybio Corporation | 9.43 Million USD | -1776.706% |
| Cue Biopharma, Inc. | 24.44 Million USD | -624.426% |
| MeiraGTx Holdings plc | 319.99 Million USD | 44.659% |
| Omeros Corporation | 403.25 Million USD | 56.086% |
| Humacyte, Inc. | 114.67 Million USD | -54.422% |
| Immunocore Holdings plc | 228.15 Million USD | 22.384% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -3532.533% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -130.761% |
| Blueprint Medicines Corporation | 918.64 Million USD | 80.723% |
| CalciMedica, Inc. | 4.02 Million USD | -4296.375% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -914.703% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -14.884% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -106.353% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 36.253% |
| Pulmatrix, Inc. | 15.96 Million USD | -1009.353% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1022.716% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -619.686% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | 29.394% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -248.691% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 85.373% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -457.172% |
| Nutriband Inc. | 1.07 Million USD | -16313.28% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -1565.438% |
| Vor Biopharma Inc. | 59.1 Million USD | -199.618% |
| Roivant Sciences Ltd. | 773.95 Million USD | 77.119% |
| Evogene Ltd. | 17.99 Million USD | -884.358% |
| ProKidney Corp. | 29.21 Million USD | -506.127% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -146.025% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -25019.187% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 90.625% |
| CorMedix Inc. | 11.91 Million USD | -1385.929% |
| BioLineRx Ltd. | 50.7 Million USD | -249.268% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -18.485% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -100.231% |
| Atai Life Sciences N.V. | 49.16 Million USD | -260.209% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -468.452% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -885.892% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -42.083% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -3032.048% |
| MediciNova, Inc. | 3.89 Million USD | -4450.523% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -868.795% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -11672.449% |
| GeoVax Labs, Inc. | 3.51 Million USD | -4931.022% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 55.423% |
| Biomea Fusion, Inc. | 30.69 Million USD | -477.015% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 93.494% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1009.422% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -467.565% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -201.762% |
| Absci Corporation | 58.3 Million USD | -203.729% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -829.683% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -452.324% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -139.986% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -102.423% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -424.389% |
| Allakos Inc. | 74.79 Million USD | -136.768% |
| Imunon, Inc. | 8.53 Million USD | -1975.934% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -687.014% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -54.24% |
| BioAtla, Inc. | 48.98 Million USD | -261.503% |
| NLS Pharmaceutics AG | 10.68 Million USD | -1558.077% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -6272.292% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -35.59% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1145.769% |
| XOMA Corporation | 145.58 Million USD | -21.642% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -426.024% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -157.546% |
| aTyr Pharma, Inc. | 31.59 Million USD | -460.452% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -186.44% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -293.831% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -265.865% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -6070.244% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -2070.699% |
| Akari Therapeutics, Plc | 4.58 Million USD | -3763.133% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -898.617% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 89.264% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -43743.152% |
| UroGen Pharma Ltd. | 243.52 Million USD | 27.282% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 44.848% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -6312.54% |
| Orgenesis Inc. | 35.53 Million USD | -398.342% |
| Entera Bio Ltd. | 1.37 Million USD | -12741.624% |
| GH Research PLC | 6.7 Million USD | -2542.68% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -2504.206% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -840.646% |
| Xencor, Inc. | 283.55 Million USD | 37.549% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -5831.188% |
| Replimune Group, Inc. | 113.21 Million USD | -56.417% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -4613.338% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -71.048% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -43743.152% |
| Portage Biotech Inc. | 4.45 Million USD | -3879.461% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -11672.449% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -668.269% |
| OncoCyte Corporation | 49.29 Million USD | -259.215% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -4180.743% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -22105.587% |
| Purple Biotech Ltd. | 10 Million USD | -1669.975% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -2960.595% |
| scPharmaceuticals Inc. | 57.26 Million USD | -209.261% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -1329.494% |
| HilleVax, Inc. | 78.9 Million USD | -124.418% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -3406.653% |
| Tharimmune, Inc. | 1.81 Million USD | -9656.557% |
| Genprex, Inc. | 3.25 Million USD | -5341.754% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -552.996% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -3282.086% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -85864.078% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -49289.761% |
| OKYO Pharma Limited | 7.42 Million USD | -2286.332% |
| Savara Inc. | 37.19 Million USD | -376.14% |
| Curis, Inc. | 57.61 Million USD | -207.377% |
| Daré Bioscience, Inc. | 26.32 Million USD | -572.567% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -351.752% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -12163.573% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -750.598% |
| BeiGene, Ltd. | 2.23 Billion USD | 92.072% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -731.788% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | 32.512% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -732.406% |
| Erasca, Inc. | 78.61 Million USD | -125.269% |
| bluebird bio, Inc. | 424.62 Million USD | 58.296% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -26925.633% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 90.631% |
| DBV Technologies S.A. | 42.8 Million USD | -313.752% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -26925.633% |
| Moderna, Inc. | 4.57 Billion USD | 96.127% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -2431.608% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -10593.599% |
| Molecular Templates, Inc. | 31.17 Million USD | -468.111% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -937.411% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 69.889% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -42.232% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -545.428% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -385.753% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -218.3% |
| MacroGenics, Inc. | 154.2 Million USD | -14.837% |
| RenovoRx, Inc. | 4.46 Million USD | -3865.204% |
| Adicet Bio, Inc. | 37.12 Million USD | -377.064% |
| Prime Medicine, Inc. | 60.78 Million USD | -191.356% |
| Aditxt, Inc. | 28.53 Million USD | -520.667% |
| Adagene Inc. | 45.16 Million USD | -292.049% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -97899.458% |
| Quantum-Si incorporated | 26.63 Million USD | -564.962% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 74.614% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -5720.529% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -54.04% |
| SciSparc Ltd. | 1.59 Million USD | -11002.571% |
| Vericel Corporation | 127.7 Million USD | -38.668% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3082.199% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -107.462% |
| Generation Bio Co. | 171.63 Million USD | -3.179% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -1433.212% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -323.337% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | 29.922% |
| Invivyd, Inc. | 51.71 Million USD | -242.44% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -92.533% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -2622.201% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -134.563% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -17244.368% |
| 2seventy bio, Inc. | 310.12 Million USD | 42.899% |
| ADMA Biologics, Inc. | 193.97 Million USD | 8.707% |
| Clene Inc. | 38.95 Million USD | -354.638% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -390.097% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | 31.089% |
| GeoVax Labs, Inc. | 3.51 Million USD | -4931.022% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | 6.926% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -1353.948% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | 10.708% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -1352.144% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -268.078% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -235.13% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 52.12% |
| Evaxion Biotech A/S | 17.61 Million USD | -905.172% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -10.04% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -15.602% |
| Trevena, Inc. | 48.26 Million USD | -266.926% |
| Surrozen, Inc. | 8.14 Million USD | -2074.168% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -720.032% |
| Cingulate Inc. | 10.36 Million USD | -1609.182% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -6339.491% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -374.863% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -4837.544% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1246.662% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 44.172% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -612.648% |
| Clearmind Medicine Inc. | 3.61 Million USD | -4805.418% |
| Kronos Bio, Inc. | 54.2 Million USD | -226.721% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -276.434% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -678.067% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -782.298% |
| Statera Biopharma, Inc. | 22.67 Million USD | -680.925% |
| ImmunityBio, Inc. | 1.09 Billion USD | 83.759% |
| Korro Bio, Inc. | 51.75 Million USD | -242.182% |
| Kineta, Inc. | 7.22 Million USD | -2352.035% |
| BioVie Inc. | 9.7 Million USD | -1725.228% |
| Codexis, Inc. | 49.94 Million USD | -254.555% |
| Celularity Inc. | 102.92 Million USD | -72.047% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -83.991% |
| Celcuity Inc. | 51.45 Million USD | -244.19% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -51200.428% |
| Cibus, Inc. | 206.11 Million USD | 14.085% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -316.918% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -572.334% |
| IN8bio, Inc. | 8.77 Million USD | -1918.764% |
| Kodiak Sciences Inc. | 213.59 Million USD | 17.091% |
| Annexon, Inc. | 47.11 Million USD | -275.835% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -97.771% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -83.753% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1193.637% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 93.198% |
| Eyenovia, Inc. | 19.78 Million USD | -795.265% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2205.507% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -634.827% |
| Arcellx, Inc. | 339.75 Million USD | 47.878% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -1388.368% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | 27.879% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -1751.783% |
| Moolec Science SA | 13.94 Million USD | -1169.856% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -310.377% |
| Geron Corporation | 146.12 Million USD | -21.186% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -250.443% |
| Royalty Pharma plc | 6.29 Billion USD | 97.188% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -345.208% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -60050.269% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -7097.793% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | 6.381% |
| Humacyte, Inc. | 114.67 Million USD | -54.422% |
| Structure Therapeutics Inc. | 29.05 Million USD | -509.569% |
| 89bio, Inc. | 59.96 Million USD | -195.325% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -569.183% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -14706.522% |
| Genelux Corporation | 8.42 Million USD | -2003.159% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -2482.935% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -29.906% |
| Notable Labs, Ltd. | 4.42 Million USD | -3900.136% |
| Liquidia Corporation | 73.13 Million USD | -142.126% |
| Mustang Bio, Inc. | 17.61 Million USD | -905.085% |
| Immunovant, Inc. | 48.95 Million USD | -261.732% |
| Quantum-Si incorporated | 26.63 Million USD | -564.962% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -361.366% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -5606.929% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -139.756% |
| Acasti Pharma Inc. | 11.55 Million USD | -1432.283% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -683.298% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -6414.332% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -380.207% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -12893.876% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -2804.954% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -613.05% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -663.829% |
| PepGen Inc. | 34.63 Million USD | -411.351% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -1358.218% |
| United Therapeutics Corporation | 1.18 Billion USD | 85.021% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -2435.596% |
| Solid Biosciences Inc. | 38.45 Million USD | -360.466% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -1969.44% |
| Immuneering Corporation | 12 Million USD | -1374.69% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -56322.331% |
| Silo Pharma, Inc. | 1.56 Million USD | -11184.61% |
| Belite Bio, Inc | 4.21 Million USD | -4105.319% |
| XOMA Corporation | 145.58 Million USD | -21.642% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -7193.493% |
| Bionomics Limited | 10.15 Million USD | -1643.192% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -724.001% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -672.863% |
| uniQure N.V. | 624.01 Million USD | 71.622% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1147.524% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -97899.458% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -4.056% |
| Forte Biosciences, Inc. | 3.66 Million USD | -4730.496% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -67857.618% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -2524.663% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2205.507% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -918.731% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -1575.681% |
| Altimmune, Inc. | 16.54 Million USD | -970.588% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 71.332% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -672.863% |
| Compugen Ltd. | 55.77 Million USD | -217.501% |
| Peak Bio, Inc. | 20.75 Million USD | -753.288% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -60.313% |
| Benitec Biopharma Inc. | 4.96 Million USD | -3468.843% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -12.191% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -135.568% |
| Zura Bio Limited | 21.29 Million USD | -731.702% |
| PolyPid Ltd. | 17.46 Million USD | -913.774% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -57.551% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -135.568% |
| Instil Bio, Inc. | 99.8 Million USD | -77.439% |
| argenx SE | 444.95 Million USD | 60.201% |
| Immunome, Inc. | 28.65 Million USD | -517.929% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -2024.097% |
| Verona Pharma plc | 58.84 Million USD | -200.957% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1123.561% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1091.776% |
| CervoMed Inc. | 2.59 Million USD | -6722.159% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -3533.279% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1290.437% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -1580.93% |
| Moolec Science SA | 13.94 Million USD | -1169.856% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -7456.462% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -218.527% |
| AnaptysBio, Inc. | 364.28 Million USD | 51.388% |
| Design Therapeutics, Inc. | 11.95 Million USD | -1381.148% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1296.137% |
| NeurAxis, Inc. | 1.91 Million USD | -9158.242% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -354.906% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1228.178% |
| Achilles Therapeutics plc | 19.08 Million USD | -827.783% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1123.561% |
| 180 Life Sciences Corp. | 5.38 Million USD | -3187.157% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -650.746% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -678.067% |
| Nutriband Inc. | 1.07 Million USD | -16313.28% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -478.75% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1120.357% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 55.869% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -445.333% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1257.075% |
| Palisade Bio, Inc. | 2.73 Million USD | -6365.352% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -3271.14% |
| Beam Therapeutics Inc. | 478.38 Million USD | 62.983% |
| Neurogene Inc. | 36.54 Million USD | -384.517% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 55.501% |
| AEON Biopharma, Inc. | 159.88 Million USD | -10.756% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -271.639% |
| Sesen Bio, Inc. | 30.98 Million USD | -471.54% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -582.123% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -2229.4% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | 9.529% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | 7.795% |
| Athira Pharma, Inc. | 30.05 Million USD | -489.167% |
| Vaccinex, Inc. | 5.94 Million USD | -2880.242% |
| HCW Biologics Inc. | 15.05 Million USD | -1076.499% |
| XOMA Corporation | 145.58 Million USD | -21.642% |
| Nektar Therapeutics | 267.04 Million USD | 33.687% |
| Arvinas, Inc. | 644.6 Million USD | 72.528% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -898.617% |
| Merus N.V. | 102.15 Million USD | -73.357% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -21.002% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -86.171% |
| Rezolute, Inc. | 11.73 Million USD | -1409.17% |
| Clene Inc. | 38.95 Million USD | -354.638% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -6119.261% |
| BeyondSpring Inc. | 48.26 Million USD | -266.873% |
| Synlogic, Inc. | 32.89 Million USD | -438.337% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1111.839% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -10737.576% |
| Peak Bio, Inc. | 20.75 Million USD | -753.288% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -179.056% |
| Krystal Biotech, Inc. | 39.71 Million USD | -345.903% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 52.983% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -77.853% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -40823.356% |
| MannKind Corporation | 721.36 Million USD | 75.451% |
| Ikena Oncology, Inc. | 22.33 Million USD | -692.863% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -8389.262% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -72.615% |
| Gossamer Bio, Inc. | 249.14 Million USD | 28.923% |
| CohBar, Inc. | 1.03 Million USD | -17032.304% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -1556.713% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -829.683% |
| Legend Biotech Corporation | 589.93 Million USD | 69.982% |
| Mural Oncology plc | 37.92 Million USD | -366.9% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -33.513% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -7615.05% |
| Disc Medicine, Inc. | 22.87 Million USD | -674.146% |
| Champions Oncology, Inc. | 28.03 Million USD | -531.66% |
| REGENXBIO Inc. | 262.22 Million USD | 32.469% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -5171.433% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -1312.845% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1218.426% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -735.114% |
| Vaxart, Inc. | 34.02 Million USD | -420.458% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -768.526% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -520.66% |
| Cellectis S.A. | 249.57 Million USD | 29.045% |
| Longeveron Inc. | 5.33 Million USD | -3218.081% |
| Repare Therapeutics Inc. | 41.81 Million USD | -323.458% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 92.637% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -193.344% |
| Revolution Medicines, Inc. | 262.39 Million USD | 32.512% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -8304.651% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -1952.933% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -1400.602% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1161.027% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -8132.729% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 96.561% |
| Denali Therapeutics Inc. | 122.96 Million USD | -44.016% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3082.199% |
| Veru Inc. | 32.81 Million USD | -439.687% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -2478.046% |
| Cingulate Inc. | 10.36 Million USD | -1609.182% |
| Passage Bio, Inc. | 39.26 Million USD | -351.037% |
| Context Therapeutics Inc. | 4.19 Million USD | -4124.667% |
| Exicure, Inc. | 8.54 Million USD | -1971.424% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -500.129% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -1588.785% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -703.439% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -8.651% |
| Nuvalent, Inc. | 31.82 Million USD | -456.472% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -2683.659% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -180.991% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -883.811% |
| OmniAb, Inc. | 87.4 Million USD | -102.616% |
| Anew Medical, Inc. | 8.24 Million USD | -2048.633% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -362.497% |
| Lipocine Inc. | 2.63 Million USD | -6629.14% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -574.048% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -340.381% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -564.692% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -105.546% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -3178.763% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -114.009% |
| Ocugen, Inc. | 23.98 Million USD | -638.381% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -281.593% |
| Q32 Bio Inc. | 233.12 Million USD | 24.039% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -1853.298% |
| Alumis Inc. Common Stock | 53.5 Million USD | -230.989% |
| Equillium, Inc. | 27.95 Million USD | -533.423% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | 14.282% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -3047.264% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -2787.444% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -12.56% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -155.046% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -1675.44% |
| Dominari Holdings Inc. | 4.63 Million USD | -3720.626% |
| Edesa Biotech, Inc. | 1.84 Million USD | -9515.684% |
| vTv Therapeutics Inc. | 29.56 Million USD | -498.931% |
| Bio-Techne Corporation | 744.34 Million USD | 76.209% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -40.434% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 48.59% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -336.441% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -511.548% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -91.735% |
| Nkarta, Inc. | 105.6 Million USD | -67.695% |
| BioCardia, Inc. | 4.59 Million USD | -3758.083% |
| Iterum Therapeutics plc | 32.66 Million USD | -442.177% |